KBC Group’s Privia Health PRVA Stock Holding History

KBC Group’s Portfolio PRVA Stock Details PRVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$71K	Hold	3,597	–	–	﹤0.01%	1596
2026 Q2	$93K	Hold	3,597	–	–	﹤0.01%	1465
2026 Q1	$74K	Hold	3,597	–	–	﹤0.01%	1486
2025 Q4	$85K	Hold	3,597	–	–	﹤0.01%	1393
2025 Q3	$90K	Hold	3,597	–	–	﹤0.01%	1331
2025 Q2	$83K	Sell	3,597 -1,415	-28%	-$32.8K	﹤0.01%	1322
2025 Q1	$113K	Hold	5,012	–	–	﹤0.01%	1414
2024 Q4	$98K	Buy	5,012 +1,627	+48%	+$32.2K	﹤0.01%	1570
2024 Q3	$62K	Buy	3,385 +871	+35%	+$16.6K	﹤0.01%	1614
2024 Q2	$44K	Hold	2,514	–	–	﹤0.01%	1695
2024 Q1	$49K	Hold	2,514	–	–	﹤0.01%	1574
2023 Q4	$58K	Sell	2,514 -344	-12%	-$7.7K	﹤0.01%	1413
2023 Q3	$66K	Sell	2,858 -4,520	-61%	-$115K	﹤0.01%	1236
2023 Q2	$193K	Buy	+7,378	New	+$195K	﹤0.01%	950

Other funds holding PRVA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.41B AUM 6.54% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

KBC Group's PRVA Position: Q3 2026 in Review

KBC Group held its Privia Health (PRVA) position steady in Q3 2026 at 3,597 shares worth $71K. The position accounts for ﹤0.01% of the portfolio, ranked #1596.

KBC Group first reported a position in PRVA in Q2 2023 and has held it in 14 quarters since. The position peaked at $193K in Q2 2023. 188 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

KBC Group held 3,597 shares of Privia Health worth $71K as of Q3 2026.
KBC Group left its Privia Health share count unchanged in Q3 2026.
Privia Health made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1596 holding.
KBC Group first reported a position in Privia Health in Q2 2023 and has held it in 14 quarters since.
KBC Group's Privia Health position peaked at $193K in Q2 2023.
188 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.